Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis

Clinical Immunology

Volumn 139, Issue 3, 2011, Pages 249-257

  Fenoglio, Daniela ^a   Battaglia, Florinda ^a   Parodi, Alessia ^a   Stringara, Silvia ^a   Negrini, Simone ^a   Panico, Nicoletta ^a   Rizzi, Marta ^a   Kalli, Francesca ^a   Conteduca, Giuseppina ^a   Ghio, Massimo ^a   De Palma, Raffaele ^b   Indiveri, Francesco ^a   Filaci, Gilberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Systemic sclerosis; Th17 cells; Treg

Indexed keywords

BOSENTAN; CANDIDA ALBICANS ANTIGEN; CANDIDA ANTIGEN; CYCLOSPORIN A; HYDROXYCHLOROQUINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONING; CELL COMPARTMENTALIZATION; CELL EXPANSION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC SCLEROSIS; T LYMPHOCYTE SUBPOPULATION; TH17 CELL;

AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 79955974107     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.01.013     Document Type: Article

References (42)

1. Gabrielli A., Avvedimento E.V., Krieg T. Scleroderma. N. Engl. J. Med. 2009, 360:1989-2003.
2. Kawaguchi Y., McCarthy S.A., Watkins S.C., Wright T.M. Autocrine activation by interleukin 1α induces the fibrogenic phenotype of systemic sclerosis fibroblasts. J. Rheumatol. 2004, 31:1946-1954.
3. Denton C.P., Abraham D.J. Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr. Opin. Rheumatol. 2001, 13:505-511.
4. Koch A.E., Kronfeld-Harrington L.B., Szekanecz Z., Cho M.M., Haines G.K., Harlow L.A., Strieter R.M., Kunkel S.L., Massa M.C., Barr W.G., Jimenez S.A. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology 1993, 61:239-246.
5. Gu Y.S., Kong J., Cheema G.S., Keen C.L., Wick G., Gershwin M.E. The immunobiology of systemic sclerosis. Semin. Arthritis Rheum. 2008, 38:132-160.
6. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
7. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-248.
8. Benwell R.K., Lee D.R. Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells. Clin. Immunol. 2010, 134:178-187.
9. Kurasawa K., Hirose K., Sano H., Endo H., Shinkai H., Nawata Y., Takabayashi K., Iwamoto I. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum. 2000, 43:2455-2463.
10. Murata M., Fujimoto M., Matsushita T., Hamaguchi Y., Hasegawa M., Takehara K., Komura K., Sato S. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?. J. Dermatol. Sci. 2008, 50:240-242.
11. Radstake T.R., van Bon L., Broen J., Hussiani A., Hesselstrand R., Wuttge D.M., Deng Y., Simms R., Lubberts E., Lafyatis R. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS ONE 2009, 4:e5903.
12. Chen W., Konkel J.E. TGF-β and 'adaptive' Foxp3+ regulatory T cells. J. Mol. Cell. Biol. 2010, 2:30-36.
13. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
14. Brusko T.M., Putnam A.L., Bluestone J.A. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol. Rev. 2008, 223:371-390.
15. van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., Taams L.S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004, 50:2775-2785.
16. Lyssuk E.Y., Torgashina A.V., Soloviev S.K., Nassonov E.L., Bykovskaia S.N. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv. Exp. Med. Biol. 2007, 601:113-119.
17. Liu M.F., Wang C.R., Fung L.L., Decreased C.R.Wu. CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand. J. Immunol. 2004, 59:198-202.
18. Hsu W., Zhang W., Tsuneyama K., Moritoki Y., Ridgway W.M., Ansari A.A., Coppel R.L., Lian Z.X., Mackay I., Gershwin M.E. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice. Hepatology 2009, 49:133-140.
19. Filaci G., Rizzi M., Setti M., Fenoglio D., Fravega M., Basso M., Ansaldo G., Ceppa P., Borgonovo G., Murdaca G., Ferrera F., Picciotto A., Fiocca R., Torre G., Indiveri F. Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann. NY Acad. Sci. 2005, 1050:115-123.
20. Liu H., Rohowsky-Kochan C. Regulation of IL-17 in human CCR6+ effector memory T cells. J. Immunol. 2008, 180:7948-7957.
21. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., Ho A.W., Hai J.H., Yu J.J., Jung J.W., Filler S.G., Masso-Welch P., Edgerton M., Gaffen S.L. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 2009, 206:299-311.
22. van de Veerdonk F.L., Marijnissen R.J., Kullberg B.J., Koenen H.J., Cheng S.C., Joosten I., van den Berg W.B., Williams D.L., van der Meer J.W., Joosten L.A., Netea M.G., et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009, 5:329-340.
23. Filaci G., Fravega M., Negrini S., Procopio F., Fenoglio D., Rizzi M., Brenci S., Contini P., Olive D., Ghio M., Setti M., Accolla R.S., Puppo F., Indiveri F. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum. Immunol. 2004, 65:142-156.
24. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol. Today 1991, 12:256-257.
25. Romagnani S. The Th1/Th2 paradigm. Immunol. Today 1997, 18:263-266.
26. Singh V.K., Mehrotra S., Agarwal S.S. The paradigm of Th1 and Th2 cytokines: its relevance to autoimmunity and allergy. Immunol. Res. 1999, 20:147-161.
27. D'Elios M.M., Romagnani P., Scaletti C., Annunziato F., Manghetti M., Mavilia C., Parronchi P., Pupilli C., Pizzolo G., Maggi E., Del Prete G.F., Romagnani S. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J. Leukoc. Biol. 1997, 61:539-544.
28. White Needelman R., Wigley F.M., Stair R.W. IL-1, IL-2, IL-4, lL-6, TNF-alpha, IFN-gamma levels in sera from patients with seleroderma. Arthritis Rheum. 1992, 35:1402-1403.
29. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
30. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
31. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
32. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 2006, 116:1218-1222.
33. El-Behi M., Rostami A., Ciric B. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 2010, 5:189-197.
34. Liu Z.J., Yadav P.K., Su J.L., Wang J.S., Fei K. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J. Gastroenterol. 2009, 15:5784-5788.
35. Gaffen S.L. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Curr. Rheumatol. Rep. 2009, 11:365-370.
36. Nalbandian A., Crispín J.C., Tsokos G.C. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin. Exp. Immunol. 2009, 157:209-215.
37. Deleuran B., Abraham D.J. Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma. Nat. Clin. Pract. Rheumatol. 2007, 3:682-683.
38. Rueda B., Broen J., Torres O., Simeon C., Ortego-Centeno N., Schrijvenaars M.M., Vonk M.C., Fonollosa V., van den Hoogen F.H., Coenen M.J., Sanchez-Román J., Aguirre-Zamorano M.A., García-Portales R., Pros A., Camps M.T., Gonzalez-Gay M.A., Martin J., Radstake T.R. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype. Ann. Rheum. Dis. 2009, 68:253-256.
39. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., Sallusto F., Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8:639-646.
40. Schirmer C., Klein C., von Bergen M., Simon J.C., Saalbach A. Human fibroblasts support the expansion of IL-17 producing T-cells via up-regulation of IL-23 production by dendritic cells. Blood 2010, 116:1715-1725.
41. Radstake T.R., van Bon L., Broen J., Wenink M., Santegoets K., Deng Y., Hussaini A., Simms R., Cruikshank W.W., Lafyatis R. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS ONE 2009, 4:e5981.
42. Weaver C.T., Hatton R.D. Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat. Rev. Immunol. 2009, 9:883-889.